603108 润达医疗
2023/09 - 九个月
人民幣(K¥)
与去年同期
比较
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
2019/12
人民幣(K¥)
营业总收入6,890,332-9.74%10,494,4198,860,1087,069,1567,051,950
减:营业总成本6,503,471-7.32%9,643,2848,160,2466,523,5706,411,799
    其中:营业成本5,109,831-9.36%7,557,0676,468,0945,157,4355,136,604
               财务费用240,5351.39%323,591291,634241,605231,009
               资产减值损失(365)19.40%(40,772)(7,299)(737)(48,504)
公允价值变动收益--------(3,589)(11,179)
投资收益190,28997.18%137,048137,876139,857131,118
    其中:对联营企业和合营企业的投资收益101,0223.22%138,057133,628133,634125,879
营业利润545,309-12.35%816,373777,798643,762676,838
利润总额554,643-12.31%819,651780,456635,836685,693
减:所得税费用140,97912.67%164,541182,255132,005174,591
净利润413,664-18.47%655,110598,201503,830511,101
减:非控股权益130,211-35.33%237,364217,972173,849201,592
股东净利润283,453-7.38%417,746380,229329,981309,510

市场价值指针
每股收益 (元) *0.490-7.55%0.7200.6600.5700.530
每股派息 (元) *----0.150--0.114--
每股净资产 (元) *6.8538.61%6.5195.7855.3374.760
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容